https://www.selleckchem.com/pr....oducts/pf-06873600.h
6±183.3 . 578.7±166.4 nmol/L, P=0.003; 394.5±298.9 . 549.2±217.7 nmol/L, P=0.002; 397.3±282.3 . 544.3±187.6 nmol/L, P=0.003). Similarly, the PBMAH patients had significantly lower levels of basal 24 hours UFC, low dose dexamethasone suppressed 24 hours UFC, and high dose dexamethasone suppressed 24 hours UFC than the UAA patients (1,144.4±1,048.1 . 1,674.9±1,520.4 nmol/24 h, P=0.032; 1,157.3±1,483.5 . 1,940.1±1,360.9 nmol/24 h, P=0.003; 1,256.4±1,767.0 . 1,969.9±1,361.7 nmol/24 h, P=0.011). PBMAH is often associated with atypical CS
Mi piace
Commento
Condividi
